GlassScriptPhysician profile
Breena R Till
NPI 1376976183
$1,058.77
in general payments reported to CMS, 2019-2025
17 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $310 · 2023: $63.39 · 2024: $42.89 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $372.60 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $184.84 | 2021-2025 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $90.09 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $81.80 | 2022-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $65.65 | 2022 | |
| Neurocrine Biosciences, INC. | $55.14 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.12 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $31.85 | 2025 | Gemtesa |
| Pfizer INC. | $29.07 | 2023 | |
| Upsher-Smith Laboratories LLC | $18.76 | 2021 | |
| Exact Sciences Corporation | $16.96 | 2024 | Cologuard Collection Kit |
| Tris Pharma INC | $16.74 | 2025 | Dyanavel Xr |
| Abbott Laboratories | $14.90 | 2021 | |
| Abbvie INC. | $14.67 | 2023 | |
| Corcept Therapeutics | $14.34 | 2025 | Korlym |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11.26 | 2021 | |
| Genentech USA, INC. | $5.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breena Till listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.